Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2016
  • IPO: 2021

• Founders

  • Chris Gibson, PhD
  • Blake Borgeson, PhD
  • Dean Li, PhD

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • Our Business & Administration teams are hiring! Learn more about our open positions at https://t.co/aqOm6IXQEm https://t.co/CL5fsJsyYE@RecursionPharma - 02:51 PM Oct 21st
  • In last week's blog, we shared how we can speed up science by increasing the precision of in vivo studies to minimi… https://t.co/68hnozuLKC@RecursionPharma - 05:35 PM Oct 20th
  • Our Business & Administration teams are hiring! Learn more about our open positions at https://t.co/aqOm6Jfs2W https://t.co/N6OHPSP6jx@RecursionPharma - 03:07 PM Oct 19th